Hypertrophic cardiomyopathy (HCM) is a relatively common often inherited global heart
disease, with complex phenotypic and genetic expression and natural history, affecting both …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …

Guidelines Liaison; cHFSA Representative; dASE Representative; eHRS Representative;
fSCMR Representative; gAATS Representative; hSCAI Representative; and iFormer Joint …

Sudden cardiac death (SCD) is the leading medical cause of death in athletes; however,
attempts to define risk have been challenged by imprecise epidemiologic methods that may …

Abstract Aim The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the
Management of Hypertrophic Cardiomyopathy” provides recommendations to guide …

Objective Evidence on the increased risk of sports-related sudden cardiac arrest and death
(SCA/D) and the potential benefit of cardiovascular preparticipation screening (PPS) in …

Premature ventricular beats (PVBs) in athletes are not rare. The risk of PVBs depends on the
presence of an underlying pathological myocardial substrate predisposing the subject to …

Our story dates back in the late 70s, when a series of juvenile sudden death (SD) occurred
in the Veneto region, north east of Italy. A successful application for a prospective study on …

Cardiomyopathies (CMP) comprise a heterogenous group of diseases affecting primarily the
myocardium, either genetic and/or acquired in origin. While many classification systems …